Description
瓣你康，伴您康复！心脏瓣膜术后管理，我们更专业！
术后科学抗凝
术后规律复查
术后健康自查
每天一点，立享美好生活。
本app仅作为提醒、监督之使用，不能替代医嘱！
术后科学抗凝
术后规律复查
术后健康自查
每天一点，立享美好生活。
本app仅作为提醒、监督之使用，不能替代医嘱！
Screenshots
瓣你康 FAQ
-
Is 瓣你康 free?
Yes, 瓣你康 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 瓣你康 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 瓣你康 cost?
瓣你康 is free.
-
What is 瓣你康 revenue?
To get estimated revenue of 瓣你康 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Portugal yet.
Ratings History
瓣你康 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
瓣你康 Installs
Last 30 days
瓣你康 Revenue
Last 30 days瓣你康 Revenue and Downloads
Gain valuable insights into 瓣你康 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Guangzhou Linteng Biotechnology Co
- Languages
- English
- Recent release
- 1.1.6 (2 years ago )
- Released on
- May 16, 2022 (2 years ago )
- Also available in
- China , Russia , Malaysia , Nigeria , Norway , New Zealand , Philippines , Pakistan , Poland , Portugal , Romania , Kuwait , Sweden , Thailand , Türkiye , Taiwan , United States , Vietnam , South Africa , France , Australia , Belarus , Chile , Denmark , Algeria , Egypt , Spain , Finland , Lebanon , Greece , Hong Kong SAR China , Hungary , Indonesia , India , Italy , Japan , United Arab Emirates
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.